Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor as predictors of disease-progression in early B-cell chronic lymphocytic leukemia.

被引：0
|
作者：
Molica, S
Vitelli, G
Levato, D
Ricciotti, A
Gandolfo, GM
机构：
[1] Azienda Osped Pugliese Ciaccio, Catanzaro, Italy
[2] Ist Regina Elena, IRCCS, I-00161 Rome, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1594
引用
收藏
页码：369A / 369A
页数：1
相关论文
共 50 条
  • [21] INCREASED INTRACELLULAR AND PLASMA-LEVELS OF BASIC FIBROBLAST GROWTH-FACTOR IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    DUENSING, S
    ATZPODIEN, J
    BLOOD, 1995, 85 (07) : 1978 - 1980
  • [22] Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia (CLL) but is a prognostic factor for disease-progression.
    Molica, S
    Vitelli, G
    Levato, D
    Giannarelli, D
    Vacca, A
    Cuneo, A
    Ribatti, D
    Digiesi, G
    BLOOD, 2003, 102 (11) : 348B - 348B
  • [23] Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor
    Rimsza, L
    Pastos, K
    Massey, K
    Braylan, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) : 753 - 758
  • [24] Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma
    Alshenawy, Hanan AlSaeid
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2010, 14 (05) : 321 - 327
  • [25] Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors
    Sobol-Milejska, Grazyna
    Mizia-Malarz, Agnieszka
    Musiol, Katarzyna
    Chudek, Jerzy
    Bozentowicz-Wikarek, Maria
    Wos, Halina
    Mandera, Marek
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (04): : 571 - 575
  • [26] Elevated serum thymidine kinase levels identify a subgroup at high risk of disease-progression in early, non-smoldering chronic lymphocytic leukemia.
    Hallek, M
    Langenmayer, I
    Nerl, C
    Knauf, W
    Dietzfelbinger, H
    Adorf, D
    Ostwald, M
    Busch, R
    Kuhn-Hallek, I
    Thiel, E
    Emmerich, B
    BLOOD, 1998, 92 (10) : 433A - 433A
  • [27] Serum levels of mast cell tryptase, vascular endothelial growth factor and basic fibroblast growth factor in patients with acute pancreatitis
    Mentula, P
    Kylänpää, ML
    Kemppainen, E
    Eklund, KK
    Orpana, A
    Puolakkainen, P
    Haapiainen, R
    Repo, H
    PANCREAS, 2003, 27 (02) : E29 - E33
  • [28] Serum levels of mast cell tryptase, vascular endothelial growth factor, and basic fibroblast growth factor in patients with acute pancreatitis
    Ferrero, S
    PANCREAS, 2004, 28 (04) : 450 - 450
  • [29] Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levels
    Iwasaki, T
    Sano, H
    LEUKEMIA & LYMPHOMA, 2003, 44 (08) : 1275 - 1279
  • [30] Serum levels of B-cell activating factor are associated with a reduced risk of chronic lymphocytic leukemia
    Frost, Eleanor
    Hofmann, Jonathan N.
    Huang, Wen-Yi
    Frazer-Abel, Ashley A.
    Deane, Kevin D.
    Berndt, Sonja I.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
12345